Recent work suggests that MDSCs induce an impaired immune activity by blocking CD8+ T cell and NK cells activation, M1 polarization, tumor antigen presentation to DCs, and inducing M2 switch [5,6,8,33]. The gene discussed is CD8A; the disease is neoplasm.